SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 124 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31 | -8.8% | 19,220 | +70.1% | 0.00% | -25.0% |
| Q2 2023 | $34 | +61.9% | 11,300 | +197.4% | 0.00% | +100.0% |
| Q1 2023 | $21 | 0.0% | 3,800 | -2.6% | 0.00% | 0.0% |
| Q4 2022 | $21 | -99.9% | 3,900 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $25,000 | +92.3% | 3,900 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $13,000 | -51.9% | 3,900 | -2.5% | 0.00% | 0.0% |
| Q1 2022 | $27,000 | -47.1% | 4,000 | -68.3% | 0.00% | -50.0% |
| Q4 2021 | $51,000 | -10.5% | 12,600 | -17.4% | 0.00% | 0.0% |
| Q3 2021 | $57,000 | -25.0% | 15,261 | +376.9% | 0.00% | -50.0% |
| Q2 2021 | $76,000 | +300.0% | 3,200 | -3.0% | 0.00% | +300.0% |
| Q1 2021 | $19,000 | -48.6% | 3,300 | -38.9% | 0.00% | -50.0% |
| Q4 2020 | $37,000 | -82.7% | 5,400 | -73.0% | 0.00% | -84.6% |
| Q3 2020 | $214,000 | +328.0% | 19,987 | +88.6% | 0.01% | +333.3% |
| Q2 2020 | $50,000 | +35.1% | 10,600 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $37,000 | +2.8% | 10,600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $36,000 | -14.3% | 10,600 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $42,000 | +23.5% | 10,600 | 0.0% | 0.00% | +33.3% |
| Q2 2019 | $34,000 | -52.8% | 10,600 | 0.0% | 0.00% | -57.1% |
| Q1 2019 | $72,000 | +56.5% | 10,600 | +2.1% | 0.01% | +75.0% |
| Q4 2018 | $46,000 | -41.0% | 10,384 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $78,000 | -12.4% | 10,384 | 0.0% | 0.01% | -28.6% |
| Q2 2018 | $89,000 | +1.1% | 10,384 | -16.1% | 0.01% | 0.0% |
| Q1 2018 | $88,000 | -25.4% | 12,384 | 0.0% | 0.01% | +40.0% |
| Q4 2017 | $118,000 | -30.6% | 12,384 | +6.0% | 0.01% | -16.7% |
| Q3 2017 | $170,000 | +1.8% | 11,684 | -21.1% | 0.01% | 0.0% |
| Q2 2017 | $167,000 | -7.7% | 14,800 | -44.2% | 0.01% | -14.3% |
| Q1 2017 | $181,000 | +15.3% | 26,500 | +52.3% | 0.01% | +40.0% |
| Q4 2016 | $157,000 | +166.1% | 17,400 | -70.9% | 0.01% | +66.7% |
| Q3 2016 | $59,000 | -4.8% | 59,747 | +245.4% | 0.00% | -25.0% |
| Q2 2016 | $62,000 | -67.5% | 17,300 | -4.1% | 0.00% | -69.2% |
| Q1 2016 | $191,000 | +48.1% | 18,047 | -49.2% | 0.01% | +62.5% |
| Q4 2015 | $129,000 | – | 35,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $93,092,000 | 26.99% |
| ARK Investment Management | 2,406,723 | $17,665,000 | 0.88% |
| Virtus ETF Advisers LLC | 76,713 | $563,000 | 0.49% |
| Bison Wealth, LLC | 33,929 | $249,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,525 | $143,000 | 0.10% |
| Rock Springs Capital Management LP | 220,000 | $1,615,000 | 0.07% |
| FEDERATED HERMES, INC. | 1,766,681 | $12,968,000 | 0.04% |
| Spark Investment Management LLC | 79,500 | $583,000 | 0.04% |
| A.R.T. Advisors, LLC | 45,952 | $337,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 88,684 | $651,000 | 0.01% |